Pharmacokinetics of Systemically Administered Antibiotics in Patients with Thermal Injury

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Patients who sustain thermal injury may require adjustments of antibiotic dosing because of pharmacokinetic alterations and pathological changes that occur in this patient subset. In general, studies of gentamicin, tobramycin, and amikacin have demonstrated lower elimination half-lives in burn patients than in nonburn patients and healthy volunteers. Other studies have shown a strong correlation between vancomycin clearance and creatinine clearance and the need for higher vancomycin dosages for burn patients than for nonburn patients. Studies of ceftazidime, ticarcillin, enoxacin, and aztreonam have shown increases in the volume of distribution or decreases in the maximum concentration achieved. Total and renal drug clearance of aztreonam was highly correlated with creatinine clearance. With imipenem, the half-life, clearance, and volume of distribution observed in burn patients were not significantly different from those in nonburn patients, although substantial interpatient variability existed. Imipenem clearance was significantly correlated with creatinine clearance. Individualization of antibiotic therapy for burn patients is recommended with use of measured serum concentrations of the antibiotic or creatinine clearance as an estimate of renal function.

Original languageEnglish (US)
Pages (from-to)458-463
Number of pages6
JournalClinical Infectious Diseases
Volume14
Issue number2
DOIs
StatePublished - Jan 1 1992

Fingerprint

Pharmacokinetics
Hot Temperature
Anti-Bacterial Agents
Wounds and Injuries
Creatinine
Aztreonam
Imipenem
Vancomycin
Enoxacin
Ticarcillin
Kidney
Tobramycin
Ceftazidime
Amikacin
Gentamicins
Half-Life
Healthy Volunteers
Serum
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Pharmacokinetics of Systemically Administered Antibiotics in Patients with Thermal Injury. / Boucher, Bradley; Kuhl, David A.; Hickerson, William.

In: Clinical Infectious Diseases, Vol. 14, No. 2, 01.01.1992, p. 458-463.

Research output: Contribution to journalArticle

@article{0a9ec2fea9c44ff58998dfc75a73e5d6,
title = "Pharmacokinetics of Systemically Administered Antibiotics in Patients with Thermal Injury",
abstract = "Patients who sustain thermal injury may require adjustments of antibiotic dosing because of pharmacokinetic alterations and pathological changes that occur in this patient subset. In general, studies of gentamicin, tobramycin, and amikacin have demonstrated lower elimination half-lives in burn patients than in nonburn patients and healthy volunteers. Other studies have shown a strong correlation between vancomycin clearance and creatinine clearance and the need for higher vancomycin dosages for burn patients than for nonburn patients. Studies of ceftazidime, ticarcillin, enoxacin, and aztreonam have shown increases in the volume of distribution or decreases in the maximum concentration achieved. Total and renal drug clearance of aztreonam was highly correlated with creatinine clearance. With imipenem, the half-life, clearance, and volume of distribution observed in burn patients were not significantly different from those in nonburn patients, although substantial interpatient variability existed. Imipenem clearance was significantly correlated with creatinine clearance. Individualization of antibiotic therapy for burn patients is recommended with use of measured serum concentrations of the antibiotic or creatinine clearance as an estimate of renal function.",
author = "Bradley Boucher and Kuhl, {David A.} and William Hickerson",
year = "1992",
month = "1",
day = "1",
doi = "10.1093/clinids/14.2.458",
language = "English (US)",
volume = "14",
pages = "458--463",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Pharmacokinetics of Systemically Administered Antibiotics in Patients with Thermal Injury

AU - Boucher, Bradley

AU - Kuhl, David A.

AU - Hickerson, William

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Patients who sustain thermal injury may require adjustments of antibiotic dosing because of pharmacokinetic alterations and pathological changes that occur in this patient subset. In general, studies of gentamicin, tobramycin, and amikacin have demonstrated lower elimination half-lives in burn patients than in nonburn patients and healthy volunteers. Other studies have shown a strong correlation between vancomycin clearance and creatinine clearance and the need for higher vancomycin dosages for burn patients than for nonburn patients. Studies of ceftazidime, ticarcillin, enoxacin, and aztreonam have shown increases in the volume of distribution or decreases in the maximum concentration achieved. Total and renal drug clearance of aztreonam was highly correlated with creatinine clearance. With imipenem, the half-life, clearance, and volume of distribution observed in burn patients were not significantly different from those in nonburn patients, although substantial interpatient variability existed. Imipenem clearance was significantly correlated with creatinine clearance. Individualization of antibiotic therapy for burn patients is recommended with use of measured serum concentrations of the antibiotic or creatinine clearance as an estimate of renal function.

AB - Patients who sustain thermal injury may require adjustments of antibiotic dosing because of pharmacokinetic alterations and pathological changes that occur in this patient subset. In general, studies of gentamicin, tobramycin, and amikacin have demonstrated lower elimination half-lives in burn patients than in nonburn patients and healthy volunteers. Other studies have shown a strong correlation between vancomycin clearance and creatinine clearance and the need for higher vancomycin dosages for burn patients than for nonburn patients. Studies of ceftazidime, ticarcillin, enoxacin, and aztreonam have shown increases in the volume of distribution or decreases in the maximum concentration achieved. Total and renal drug clearance of aztreonam was highly correlated with creatinine clearance. With imipenem, the half-life, clearance, and volume of distribution observed in burn patients were not significantly different from those in nonburn patients, although substantial interpatient variability existed. Imipenem clearance was significantly correlated with creatinine clearance. Individualization of antibiotic therapy for burn patients is recommended with use of measured serum concentrations of the antibiotic or creatinine clearance as an estimate of renal function.

UR - http://www.scopus.com/inward/record.url?scp=0026515792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026515792&partnerID=8YFLogxK

U2 - 10.1093/clinids/14.2.458

DO - 10.1093/clinids/14.2.458

M3 - Article

VL - 14

SP - 458

EP - 463

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 2

ER -